AIM: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. MATERIALS …

OBJECTIVE. Our study investigated the usefulness of contrast-enhanced MR imaging for
accurately measuring the size of residual tumor after patients have undergone neoadjuvant …

Background. The aim, of the study was to estimate the accuracy of magnetic resonance
imaging (MRI) in assessing residual disease in breast cancer patients receiving …

Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

OBJECTIVE. This study was undertaken to evaluate the ability of MRI to accurately show
residual primary breast malignancy in women treated with neoadjuvant chemotherapy …

Background. This study evaluated the accuracy of magnetic resonance imaging (MRI) for
estimating residual tumor size after neoadjuvant chemotherapy in patients with locally …

AIMS: We prospectively compared the ability of magnetic resonance imaging (MRI) to
measure residual breast cancer in patients treated with different neoadjuvant chemotherapy …

The purpose of this study was to evaluate the usefulness of three‐dimensional magnetic
resonance imaging (3D MRI) for the preoperative assessment of residual tumor extent in …

Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Purpose To investigate the impact of antiangiogenic therapy with bevacizumab on
pathological response and the diagnostic performance of magnetic resonance imaging …